Intelence is a prescription medication commonly used as part of an HIV "cocktail" to treat HIV and AIDS. This eMedTV article describes how the drug works, offers dosing guidelines, and explains what side effects may occur with treatment.
Potential Intelence side effects include vomiting, nausea, and abdominal pain. This eMedTV resource provides a more complete list of possible side effects, including common problems as well as serious side effects that require medical attention.
Intelence is used for treating HIV and AIDS in adults. This article from the eMedTV library explains how this HIV drug works, describes its effects, and discusses possible off-label Intelence uses.
The recommended Intelence dosage for treating HIV or AIDS is 200 mg (two tablets) twice a day after meals. This eMedTV segment offers more detailed dosing guidelines and also includes tips and precautions for using this HIV medication.
Medicines that may cause Intelence drug interactions include warfarin, diazepam, and dexamethasone. This eMedTV resource lists other medications that may interfere with Intelence and describes the potential dangers of these interactions.
Intelence can change the distribution of fat on your body. This eMedTV resource contains a list of other side effects or problems that may occur with Intelence. Warnings and precautions on who should not use this drug are also listed on this page.
It is not clear what to expect from an Intelence (etravirine) overdose. As this eMedTV page explains, the effects of an Intelence overdose will vary depending on several factors, including the dosage. Treatment options are also listed in this article.
Based on information from animal studies, Intelence (etravirine) is probably safe for use during pregnancy. This eMedTV article provides more information on Intelence and pregnancy, and explores the results of these animal studies.
Most women taking Intelence (etravirine) should not breastfeed. This eMedTV segment talks about Intelence and breastfeeding, and also explains why women with HIV or AIDS in developed countries are advised to avoid breastfeeding in general.
Intelence (etravirine) is currently not available in generic form. As this page on the eMedTV site explains, the earliest predictable date that a generic Intelence product could become available is November 2019, when the patent for the drug expires.
